Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
TTK HEALTHCARE Mar-19 |
TEVA PHARMA Dec-13 |
TTK HEALTHCARE/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,215 | 3,117 | - | |
Low | Rs | 610 | 2,708 | - | |
Sales per share (Unadj.) | Rs | 444.4 | 1,788.7 | - | |
Earnings per share (Unadj.) | Rs | 17.2 | 111.7 | - | |
Cash flow per share (Unadj.) | Rs | 27.6 | 256.3 | - | |
Dividends per share (Unadj.) | Rs | 5.00 | 97.82 | - | |
Dividend yield (eoy) | % | 0.5 | 3.4 | 16.3% | |
Book value per share (Unadj.) | Rs | 177.9 | 1,986.9 | - | |
Shares outstanding (eoy) | m | 14.13 | 848.00 | - | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 2.1 | 1.6 | 126.1% | |
Avg P/E ratio | x | 52.9 | 26.1 | 203.0% | |
P/CF ratio (eoy) | x | 33.0 | 11.4 | 290.7% | |
Price / Book Value ratio | x | 5.1 | 1.5 | 349.9% | |
Dividend payout | % | 29.0 | 87.5 | 33.1% | |
Avg Mkt Cap | Rs m | 12,894 | 2,469,486 | 0.5% | |
No. of employees | `000 | 2.3 | 44.9 | 5.1% | |
Total wages/salary | Rs m | 1,307 | 0 | - | |
Avg. sales/employee | Rs Th | 2,715.7 | 33,748.9 | 8.0% | |
Avg. wages/employee | Rs Th | 565.3 | 0 | - | |
Avg. net profit/employee | Rs Th | 105.4 | 2,108.3 | 5.0% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 6,279 | 1,516,846 | 0.4% | |
Other income | Rs m | 78 | 0 | - | |
Total revenues | Rs m | 6,356 | 1,516,846 | 0.4% | |
Gross profit | Rs m | 496 | 415,389 | 0.1% | |
Depreciation | Rs m | 147 | 122,608 | 0.1% | |
Interest | Rs m | 34 | 29,793 | 0.1% | |
Profit before tax | Rs m | 393 | 262,988 | 0.1% | |
Minority Interest | Rs m | 0 | 1,195 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -172,637 | 0.0% | |
Tax | Rs m | 149 | -3,211 | -4.6% | |
Profit after tax | Rs m | 244 | 94,756 | 0.3% | |
Gross profit margin | % | 7.9 | 27.4 | 28.8% | |
Effective tax rate | % | 37.9 | -1.2 | -3,106.5% | |
Net profit margin | % | 3.9 | 6.2 | 62.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 2,717 | 1,024,472 | 0.3% | |
Current liabilities | Rs m | 1,571 | 893,427 | 0.2% | |
Net working cap to sales | % | 18.3 | 8.6 | 211.3% | |
Current ratio | x | 1.7 | 1.1 | 150.9% | |
Inventory Days | Days | 32 | 91 | 35.4% | |
Debtors Days | Days | 47 | 96 | 48.6% | |
Net fixed assets | Rs m | 991 | 495,435 | 0.2% | |
Share capital | Rs m | 141 | 3,734 | 3.8% | |
Net worth | Rs m | 2,514 | 1,684,929 | 0.1% | |
Long term debt | Rs m | 3 | 775,597 | 0.0% | |
Total assets | Rs m | 4,158 | 3,466,480 | 0.1% | |
Interest coverage | x | 12.6 | 9.8 | 128.4% | |
Debt to equity ratio | x | 0 | 0.5 | 0.3% | |
Sales to assets ratio | x | 1.5 | 0.4 | 345.1% | |
Return on assets | % | 6.7 | 3.6 | 185.7% | |
Return on equity | % | 9.7 | 5.6 | 172.4% | |
Return on capital | % | 16.9 | 4.9 | 343.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 173 | 241,707 | 0.1% | |
From Investments | Rs m | 97 | -85,646 | -0.1% | |
From Financial Activity | Rs m | -307 | -289,944 | 0.1% | |
Net Cashflow | Rs m | -38 | -133,883 | 0.0% |
Compare TTK HEALTHCARE With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare TTK HEALTHCARE With: SUN PHARMA NATCO PHARMA IPCA LABS STRIDES PHARMA SCIENCE VENUS REMEDIES
Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.
For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.
For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.
Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.
More Views on NewsIn this video, I'll tell you why I am recommending caution in the market at this time.
A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.
In this video I'll show you exactly how I go about picking stocks for trading.
100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.
More